Global Pharmaceuticals & Biotech Blue chip stocks

Innovent Biologics

Market Cap: HK$167.0b

A biopharmaceutical company, engages in the research and development of antibody and protein medicine products in the People’s Republic of China, the United States, and internationally.

Sichuan Kelun-Biotech Biopharmaceutical

Market Cap: HK$99.2b

A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.

Caris Life Sciences

Market Cap: US$10.3b

An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.

Galderma Group

Market Cap: CHF 31.3b

Operates as a dermatology company worldwide.

Teva Pharmaceutical Industries

Market Cap: US$20.5b

Develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.

Sino Biopharmaceutical

Market Cap: HK$139.9b

An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.

Insmed

Market Cap: US$27.0b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Viatris

Market Cap: US$12.4b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Sartorius Stedim Biotech

Market Cap: €17.3b

Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.

Neurocrine Biosciences

Market Cap: US$13.2b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

Celltrion

Market Cap: ₩38.6t

A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.

Revvity

Market Cap: US$10.5b

Provides health sciences solutions, technologies, and services worldwide.

BeOne Medicines

Market Cap: US$35.4b

An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.

WuXi Biologics (Cayman)

Market Cap: HK$125.9b

An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.

Medpace Holdings

Market Cap: US$12.9b

Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.

Eurofins Scientific

Market Cap: €12.0b

Provides various analytical testing and laboratory services worldwide.

UCB

Market Cap: €36.6b

A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.

Roche Holding

Market Cap: CHF 219.5b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Genmab

Market Cap: DKK 92.1b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

CSL

Market Cap: AU$130.9b

Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Recordati Industria Chimica e Farmaceutica

Market Cap: €10.6b

Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.

Exelixis

Market Cap: US$10.3b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Orion Oyj

Market Cap: €9.5b

Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.

Chugai Pharmaceutical

Market Cap: JP¥10.3t

Engages in the research, development, manufacture, sale, importation, and exportation of pharmaceuticals in Japan and internationally.

Eli Lilly

Market Cap: US$629.5b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

argenx

Market Cap: €33.9b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Daiichi Sankyo Company

Market Cap: JP¥6.8t

Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.